Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Olsson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Lancet. Gastroenterology & Hepatology|October 10, 2017
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 studyKarl Heinz Weiss, Frederick K Askari, Anna Czlonkowska, et al.
American Heart Journal|April 29, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
American Heart Journal|July 15, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
The Plant Journal : for Cell and Molecular Biology|June 6, 2019
Genome-wide association study identified novel candidate loci affecting wood formation in Norway spruceJohn Baison, Amaryllis Vidalis, Linghua Zhou, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Lancet. Gastroenterology & Hepatology|October 10, 2017
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 studyKarl Heinz Weiss, Frederick K Askari, Anna Czlonkowska, et al.
American Heart Journal|April 29, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
American Heart Journal|July 15, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
The Plant Journal : for Cell and Molecular Biology|June 6, 2019
Genome-wide association study identified novel candidate loci affecting wood formation in Norway spruceJohn Baison, Amaryllis Vidalis, Linghua Zhou, et al.
Pageof 2